http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#Head http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#provenance http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#pubinfo http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion http://purl.obolibrary.org/obo/DOID_0050782 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0050782 http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01129 http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association http://www.w3.org/2000/01/rdf-schema#label rabeprazole sodium delayed release tablets is a proton pump inhibitor ppi indicated in adults for healing of erosive or ulcerative gastroesophageal reflux disease gerd 1 1 maintenance of healing of erosive or ulcerative gerd 1 2 treatment of symptomatic gerd 1 3 healing of duodenal ulcers 1 4 helicobacter pylori 1 5 treatment of pathological hypersecretory conditions including zollinger ellison syndrome 1 6 in adolescent patients 12 years of age and older for short term treatment of symptomatic gerd 1 7 rabeprazole sodium delayed release tablets is indicated for short term 4 to 8 weeks treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease gerd for those patients who have not healed after 8 weeks of treatment an additional 8 week course of rabeprazole sodium delayed release tablets may be considered rabeprazole sodium delayed release tablets is indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease gerd maintenance controlled studies do not extend beyond 12 months rabeprazole sodium delayed release tablets is indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks rabeprazole sodium delayed release tablets is indicated for short term up to four weeks treatment in the healing and symptomatic relief of duodenal ulcers most patients heal within four weeks rabeprazole sodium delayed release tablets in combination with amoxicillin and clarithromycin as a three drug regimen is indicated for the treatment of patients with h pylori h pylori h pylori see clinical studies 14 5 dosage and administration 2 5 in patients who fail therapy susceptibility testing should be done if resistance to clarithromycin is demonstrated or susceptibility testing is not possible alternative antimicrobial therapy should be instituted see clinical pharmacology 12 2 clinical pharmacology 12 2 rabeprazole sodium delayed release tablets is indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome rabeprazole sodium delayed release tablets is indicated for the treatment of symptomatic gerd in adolescents 12 years of age and above for up to 8 weeks http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01129 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#provenance http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#pubinfo http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig http://purl.org/nanopub/x/hasSignature T8ClaH8qWhimQpqdlB5YtASDX/HKAHhSWrjpB3R+aja7aSqox08fSaFi9HrLHgHaV6vaN71TIptkBAIaGZWhG48PiaVFyjUSzoJzGrfE0pUF0D7dvuUC2hNUauEyPrE+kuICAslaZJ6Oq0QpxhZ+oH0Ep9wEgQcXtRE1n/vwlQg= http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://purl.org/dc/terms/created 2021-06-13T15:14:34.455+02:00 http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs